Tag: price

CAMBRIDGE, Mass., June 10, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease, today announced a reverse stock split of its issued and outstanding shares of common stock, par value $0.005 per share (the “Common Stock”), at a ratio of 1-for-15, effective June 12, 2025 at 12:01 a.m. Eastern Time. The Company’s Common Stock is expected to begin trading on a split-adjusted basis when the market opens on June 12, 2025, under the existing trading symbol “ERNA.”

BOCA RATON, FL, June 10, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company” or “DeFi Dev Corp.”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced a strategic partnership with Exponent, a leading Solana-native yield strategy platform. This collaboration will see dfdvSOL, a liquid staking token (LST) adopted by DeFi Dev Corp., integrated into Exponent’s innovative fixed-yield and leverage yield farming vaults.

With this integration, Exponent users can deploy dfdvSOL across three key yield strategies, each tailored to different risk and return preferences:

In week 23 Kvika banki hf. („Kvika“ or „the bank“) purchased 16,200,000 of its own shares at the purchase price ISK 287,285,000. See further details below:

TORONTO, June 10, 2025 (GLOBE NEWSWIRE) -- Timbercreek Financial Corp. (TSX: TF) (the "Company") announced today that it has obtained the approval of the Toronto Stock Exchange (the "TSX") to commence a normal course issuer bid (the “NCIB”) with respect to its common shares (the “Shares”). The NCIB will commence on June 12, 2025 and will terminate on the earlier of June 11, 2026 or the date on which the Company has purchased the maximum number of Shares permitted under the NCIB.

Declares Quarterly Cash Dividend Of $0.50 Per Share